/PRNewswire/ The sex reassignment surgery market in US is to grow by USD 125.78 million at a CAGR of 10.84% from 2023 to 2027, according to the latest.
Allergan Aesthetics, a pharmaceutical company that makes Botox injections and breast implants, has been funding doctors who promote them to transgender people.
Allergan Aesthetics, a pharmaceutical company that produces Botox injections and breast implants, funded doctors who promote cosmetic procedures as particularly beneficial and even medically necessary for transgender people.
/PRNewswire/ The "Gender Reassignment Surgery Market by Gender Transition and Geography - Forecast and Analysis 2021-2025" report by Technavio expects the.